In this issue:
GLP1R/GCGR dual agonism reverses obesity in mice
Albiglutide in type 2 diabetes
Insulin-based vs. triple oral therapy
Exenatide vs. insulin glargine: cost effectiveness
Intensive glucose control & macrovascular outcomes
Neighbourhood physical activity/hea
Please login below to download this issue (PDF)